Viable virus shedding during SARS-CoV-2 reinfection
Lancet Respir Med
.
2021 Jul;9(7):e56-e57.
doi: 10.1016/S2213-2600(21)00219-8.
Epub 2021 May 5.
Authors
Andrew G Letizia
1
,
Darci R Smith
1
,
Yongchao Ge
2
,
Irene Ramos
2
,
Rachel S G Sealfon
3
,
Carl Goforth
1
,
Ana S Gonzalez-Reiche
4
,
Sindhu Vangeti
2
,
Dawn L Weir
1
,
Hala Alshammary
4
,
Hua Wei Chen
1
,
Mary-Catherine George
2
,
Alessandra Soares-Schanoski
2
,
Rhonda A Lizewski
5
,
Stephen E Lizewski
5
,
Jan Marayag
1
,
Clare M Miller
2
,
Edgar Nunez
1
,
Chad K Porter
1
,
Ernesto Santa Ana
1
,
Megan Schilling
1
,
Victor A Sugiharto
1
,
Peifang Sun
1
,
Michael Termini
6
,
Adriana van de Guchte
4
,
Olga G Troyanskaya
3
,
Harm van Bakel
4
,
Stuart C Sealfon
7
Affiliations
1
Naval Medical Research Center, Silver Spring, MD, USA.
2
Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
3
Center for Computational Biology, Flatiron Institute, New York, NY, USA.
4
Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
5
Naval Medical Research Unit SIX, Lima, Peru.
6
Navy Medicine Readiness and Training Command Beaufort, Beaufort, SC, USA.
7
Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address:
[email protected]
.
PMID:
33964243
PMCID:
PMC8099311
DOI:
10.1016/S2213-2600(21)00219-8
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Humans
Reinfection
SARS-CoV-2*
Virus Shedding